| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210770 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 32 Pages |
Abstract
The study showed that 1p/19q codeleted oligodendroglioma was a significant risk factor associated with cRN and the relative volume (percentage) of brain receiving 60 GyRBE was an important dosimetric predictor of cRN for oligodendroglioma patients. There is insufficient evidence at this time to conclude a significant difference in the incidence of cRN between proton and photon therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sahaja MD, Clifford G. MD, Jeff M. MD, Dan DDS, Todd A. PhD, Jian L. MD, PhD, Anupama MD, Beth CMD, Dennis E. MD, Jeffrey D. MD, Jiayi MD,